MicroRNAs (miRNAs) are small regulatory molecules post-transcriptionally suppressing
mRNA activity. Many miRNAs in various organisms have been cloned but many unknown …

For patients with venous thromboembolism (VTE), prediction of bleeding is relevant
throughout the course of treatment, although the means and goal of this prediction differ …

Effective stroke prevention with oral anticoagulation (OAC) is the cornerstone of the
management of patients with atrial fibrillation. The use of OAC reduces the risk of stroke and …

In cardiovascular disease (CVD), biomarkers (ie,“biological markers”) could have multiple
roles in understanding the complexity of cardiovascular (CV) pathophysiology and to offer …

Aims Patients with atrial fibrillation (AF) treated with oral anticoagulation still suffer from
cardiovascular complications including cardiovascular death, stroke, and major bleeding. To …

Atrial fibrillation (AF) and chronic kidney disease (CKD) are strictly related; several
independent risk factors of AF are often frequent in CKD patients. AF prevalence is very …

The appropriate use of oral anticoagulants (OACs) for prevention of stroke in atrial fibrillation
(AF) relies on the convenient and accurate stroke risk-prediction scheme: namely, the CHA 2 …

Aims To investigate the decline of estimated glomerular filtration rate (eGFR) in patients with
atrial fibrillation (AF) treated with vitamin K antagonists (VKAs) or non‐VKA oral …

Purpose Advanced chronic kidney disease (CKD), including end-stage renal disease
(ESRD) on dialysis, increases thromboembolic risk among patients with atrial fibrillation …

Objective: Atrial Fibrillation (AF) and chronic kidney disease frequently coexist in the elderly.
Warfarin-like drugs (WLDs) may be associated with a relatively greater decrease of …